• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22163 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2021     Austrian Institute for Health Technology Assessment (AIHTA) Triphasic biomaterial for augmentation of the osteoporotic femoral neck: systematic review
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Triple therapy for COPD
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2018     NIHR Health Technology Assessment programme Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2019     Penn Medicine Center for Evidence-based Practice (CEP) Triple-lumen peripherally-inserted central catheters
2000     British Columbia Office of Health Technology Assessment (BCOHTA) Triple-marker screening in British Columbia: current practice, future options
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2016     NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2011     HAYES, Inc. Trofile™ HIV tropism assay
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Troglitazone for Type II diabetes
2008     NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) TruScan
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2006     National Institute for Health and Care Excellence (NICE) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control
2010     HAYES, Inc. Tuberous Sclerosis Complex (TSC; Bourneville Disease)
2022     National Institute for Health and Care Excellence (NICE) Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies. NICE technology appraisal guidance 786
2002     Health Technology Advisory Committee (HTAC) Tumescent liposuction
2001     HAYES, Inc. Tumescent liposuction
2011     HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2024     Swiss Federal Office of Public Health (FOPH) Tumor treating fields (TTFields) therapy for patients with glioblastoma multiforme
2003     The Swedish Council on Health Technology Assessment (SBU) Tumor vaccination- early assessment briefs (Alert)
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Economic efficiency
2002     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Medical efficacy
2016     NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2023     Scottish Health Technologies Group (SHTG) Tumour profiling tests to guide chemotherapy decisions in early breast cancer
2003     The Swedish Council on Health Technology Assessment (SBU) TUNA - Transurethral needle ablation for BPH - early assessment briefs (Alert)
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2014     Health Quality Ontario (HQO) Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2014     Health Quality Ontario (HQO) Turning for ulcer reduction (TURN) study: an economic analysis
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2018     NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2020     NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2022     Medical Services Advisory Committee (MSAC) Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer disease
2006     University HealthSystem Consortium (UHC) Tygacil
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2017     Agency for Healthcare Research and Quality (AHRQ) Tympanostomy tubes in children with otitis media
2004     National Institute for Clinical Excellence (NICE) Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults
2004     National Institute for Clinical Excellence (NICE) Type 2 diabetes: Prevention and management of foot problems
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Type 2 diabetes. Health technology assessment of screening, diagnosis and treatment
2012     NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2014     Malaysian Health Technology Assessment (MaHTAS) Typhoid carrier test (Typhidot-C)
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating ALK mutation-positive advanced non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors for treating MET mutation-positive metastatic non-small-cell lung cancer
2022     Agency for Care Effectiveness (ACE) Tyrosine kinase inhibitors, immune checkpoint inhibitors and everolimus for treating advanced renal cell cancer
2022     National Institute for Health and Care Excellence (NICE) TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal). NICE technology appraisal guidance 790
2010     HAYES, Inc. UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer
2021     NIHR Health Technology Assessment programme UK Cohort study to Investigate the prevention of Parastomal Hernia (CIPHER)
2015     NIHR Health Technology Assessment programme UK DRAFFT: a randomised controlled trial of percutaneous fixation with Kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
1995     NIHR Health Technology Assessment programme UK home parenteral nutrition register
2018     NIHR Health Technology Assessment programme UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development
2020     NIHR Health Services and Delivery Research programme UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ularitide for acute decompensated heart failure – first line
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ulipristal Acetate (Fibristal - Actavis Specialty Pharmaceuticals Co.) indication: uterine fibroids
2022     NIHR Health Technology Assessment programme Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): a randomised controlled trial and exploration of mechanism of action (UCON trial)
2015     Adelaide Health Technology Assessment (AHTA) Ultra-filtration for patients with decompensated heart failure
2023     Health Information and Quality Authority (HIQA) Ultra-hypofractionated adjuvant radiotherapy for breast cancer: evidence synthesis to support a generic justification decision
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ultra-low-dose Danazol (Optina; Vasaloc) for diabetic macular oedema
2003     Adelaide Health Technology Assessment (AHTA) Ultrafast magnetic resonance imaging (MRI) for patients undergoing conventional MRI
2007     HAYES, Inc. Ultrafiltration for acute decompensated congestive heart failure
2006     NIHR Horizon Scanning Centre (NIHR HSC) Ultrafiltration for acute decompensated heart failure: horizon scanning technology briefing
2010     VA Technology Assessment Program (VATAP) Ultrafiltration for decompensated heart failure
2008     VA Technology Assessment Program (VATAP) Ultrafiltration for heart failure
2013     HAYES, Inc. Ultrafiltration in congestive heart failure
2015     Health Quality Ontario (HQO) Ultrafiltration in heart failure: a rapid review
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ultrasonic cutting and coagulating devices
2014     Agenzia nazionale per i servizi sanitari regionali (Agenas) Ultrasonic energy devices for surgery
2014     Malaysian Health Technology Assessment (MaHTAS) Ultrasonic wound debridement device
1998     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Ultrasonography in primary health care. IPE-98/16 (Public report)
2002     Blue Cross Blue Shield Association (BCBS) Ultrasonography of peripheral sites for selecting patients for pharmacologic treatment for osteoporosis
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation
2000     ECRI Ultrasound bone densitometry for diagnosis of osteoporosis
2015     HAYES, Inc. Ultrasound bone growth stimulation
2003     HAYES, Inc. Ultrasound bone growth stimulation
2009     HAYES, Inc. Ultrasound bone growth stimulation
2003     Institute for Clinical Systems Improvement (ICSI) Ultrasound cervical length for the prediction of preterm labor
2000     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Ultrasound diagnostic during pregnancy
2007     Adelaide Health Technology Assessment (AHTA) Ultrasound for assessment of risk of fracture
2012     HAYES, Inc. Ultrasound guidance to aid in the placement of peripherally inserted central catheter lines
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound imaging in the practice of anaesthesia
2004     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Ultrasound in pregnancy - Evaluation of the routine ultrasound examinations according to the German Maternity Code
2004     Malaysian Health Technology Assessment Unit (MHTAU) Ultrasound in primary and antenatal care
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound of peripheral nerves
2001     Centre for Clinical Effectiveness (CCE) Ultrasound or venogram for diagnosis of deep vein thrombosis (DVT)?
2006     Medical Advisory Secretariat (MAS) Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis
2003     Adelaide Health Technology Assessment (AHTA) Ultrasound screening for hip dysplasia: a new screening programme for the early detection of hip dysplasia in neonates
2000     NIHR Health Technology Assessment programme Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views
2003     ECRI Ultrasound screening of normal-risk women for prevention of postterm pregnancy
2014     HAYES, Inc. Ultrasound transient elastography for detecting hepatic fibrosis in patients with hepatitis C
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Ultrasound treatment - nonunion fractures
1997     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Ultrasound treatment - systematic review
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Ultrasound versus computed tomography for children with suspected appendicitis: clinical evidence, cost-effectiveness, and guidelines
1999     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ultrasound-assisted lipoplasty